Literature DB >> 19413507

Anemia-related hemogram, uterine artery pulsatility index, and blood pressure for the effects of Four-Agents-Decoction (Si Wu Tang) in the treatment of primary dysmenorrhea.

Lan Lan Liang Yeh1, Jah-Yao Liu, Yu-Shen Liu, Kao-Si Lin, Te-Feng Tsai, Li-Hsiang Wang.   

Abstract

OBJECTIVES: We previously reported pain intensity as the primary outcome of Four-Agents-Decoction (Si Wu Tang) for treating primary dysmenorrhea. We further explored other effects of this formula in accordance with the theory of Traditional Chinese Medicine on anemia-related hemogram parameters for "nourishing blood" and uterine artery pulsatility index (PI) for "blood stagnation."
DESIGN: Data were assessed for post-hoc analysis from 76 young women from the Taipei metropolitan area of Taiwan who participated in the randomized double-blind clinical trial. Analysis of variance and t test were used to examine the treatment effect between and within the Four-Agents-Decoction and placebo groups. OUTCOME MEASURES: In addition to pain intensity, anemia-related hemogram parameters, uterine artery PI, menstruation characteristics, and blood pressure were compared.
RESULTS: Compared to placebo, biochemical indicators for anemic status did not change differently after the treatment with Four-Agents-Decoction (Si Wu Tang). The changes in uterine artery PI, menstrual pain intensity, and blood pressure were statistically greater in the active treatment group than in the placebo group. In the 25 women receiving ultrasound examination on the same menstruation day, the directions of the changes in both PI and in visual analog scale (VAS) pain intensity aligned well. The changes in the left PI, right PI, and VAS pain intensity in the Four-Agents-Decoction group were -0.391 +/- 0.861, -0.344 +/- 1.03, and -0.251 +/- 2.02 cm; those in the placebo group were 0.208 +/- 1.10, 0.372 +/- 1.06, and 0.438 +/- 2.98 cm, respectively. Inversely, the changes in blood pressure were 11.4 +/- 10.5 mm Hg for systolic blood pressure and 8.36 +/- 8.65 mm Hg for diastolic pressure for the Four-Agents-Decoction group and 6.36 +/- 8.66 and 2.91 +/- 11.2 mm Hg, respectively, for the placebo group. The directions of the changes did not shift, nor did the values change drastically, after adjusting for the level at screening cycle.
CONCLUSIONS: The anemia status evaluated in conventional medicine does not readily explain the effect of "nourishing blood" by Four-Agents-Decoction (Si Wu Tang) from this exploratory study. Although we did not find strong statistical significance of treatment effect, the decreased PI and extra blood pressure elevation may indicate an improvement of "blood stagnation" in the Four-Agents-Decoction group. The added information warrants a further larger clinical trial with an increased power to enhance our understanding of the efficacy, the dose-response relationship, and the mode of action of this ancient formula for treating primary dysmenorrhea.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413507     DOI: 10.1089/acm.2008.0208

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  11 in total

1.  The association between socioeconomic status and traditional chinese medicine use among children in Taiwan.

Authors:  Chun-Chuan Shih; Chien-Chang Liao; Yi-Chang Su; Tsu F Yeh; Jaung-Geng Lin
Journal:  BMC Health Serv Res       Date:  2012-02-01       Impact factor: 2.655

2.  Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study.

Authors:  Ming-Chen Chen; Jung-Nien Lai; Pau-Chung Chen; Jung-Der Wang
Journal:  J Tradit Complement Med       Date:  2013-10

3.  The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats.

Authors:  Xiao Yu; Xiao-Dong Zhao; Rong-Qi Bao; Jia-Yu Yu; Guo-Xing Zhang; Jing-Wei Chen
Journal:  BMC Complement Altern Med       Date:  2017-06-21       Impact factor: 3.659

4.  Network Pharmacology-Based Investigation of the System-Level Molecular Mechanisms of the Hematopoietic Activity of Samul-Tang, a Traditional Korean Herbal Formula.

Authors:  Ho-Sung Lee; In-Hee Lee; Sang-In Park; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-13       Impact factor: 2.629

5.  Hematopoietic Effects of Paeoniflorin and Albiflorin on Radiotherapy-Induced Myelosuppression Mice.

Authors:  Yingli Zhu; Linyuan Wang; Zhihui Yang; Jingxia Wang; Wei Li; Jianyu Zhou; Jianjun Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-26       Impact factor: 2.629

6.  Vascular Protective Role of Samul-Tang in HUVECs: Involvement of Nrf2/HO-1 and NO.

Authors:  Eun Sik Choi; Yun Jung Lee; Chang Seob Seo; Jung Joo Yoon; Byung Hyuk Han; Min Cheol Park; Dae Gill Kang; Ho Sub Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-05       Impact factor: 2.629

7.  To Unveil the Molecular Mechanisms of Qi and Blood through Systems Biology-Based Investigation into Si-Jun-Zi-Tang and Si-Wu-Tang formulae.

Authors:  Jing Sun; Li Zhang; Yujun He; Kun Zhang; Liping Wu; Yongsheng Fan; Zhijun Xie
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

8.  Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer.

Authors:  Yueh-Ting Tsai; Jung-Nien Lai; Pei-Chia Lo; Chin-Nu Chen; Jaung-Geng Lin
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

9.  Samul-Tang Regulates Cell Cycle and Migration of Vascular Smooth Muscle Cells against TNF-α Stimulation.

Authors:  Eun Sik Choi; Jung Joo Yoon; Byung Hyuk Han; Da Hye Jeong; Hye Yoom Kim; You Mee Ahn; So Young Eun; Yun Jung Lee; Dae Gill Kang; Ho Sub Lee
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

10.  Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Jungtae Leem; Junyoung Jo; Chan-Young Kwon; Hojung Lee; Kyoung Sun Park; Jin Moo Lee
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.